logo
logo

Basilea partners with BARDA to develop novel antifungals and antibacterials, receives initial funding

Basilea partners with BARDA to develop novel antifungals and antibacterials, receives initial funding

09/19/24, 5:16 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CH.svgbasel landschaft
Money
$29 million
Industry
biopharma
biotechnology
Type
agreement
Basilea Pharmaceutica Ltd has entered into a partnership agreement with the Biomedical Advanced Research and Development Authority (BARDA) to develop urgently needed novel antifungals and antibacterials. Basilea has received an initial funding of USD 29 million from BARDA to support the development of the antifungals fosmanogepix and BAL2062. The agreement includes a potential non-dilutive funding of up to approximately USD 268 million over up to twelve years.

Company Info

Company
Basilea Pharmaceutica Ltd
Location
basel landschaft, switzerland
Additional Info
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company dedicated to meeting the needs of patients with severe bacterial and fungal infections.